Empowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology
NCT02205086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-07-31
Summary
This study compares the ability of clinicians to make diagnoses with or without the assistance of diagnostic decision support software. The area of clinical focus is primarily rheumatology.
Conditions
- Rheumatology
Interventions
- OTHER
-
Diagnosis
Unaided: The testers will record a differential diagnosis consisting of a list of diseases and their ranking and a prioritized list of test orders, as well as the most appropriate referral for further evaluation and treatment of the patient. Aided: Then testers will enter the case into diagnostic decision support software and after getting advice from the software, the testers will record the same information as in Unaided, but allowing for the possibility that responses could differ as a result of using the software.
Sponsors & Collaborators
-
SimulConsult, Inc.
lead INDUSTRY
Principal Investigators
-
Michael M Segal, MD PhD · SimulConsult, Inc.
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 ·Status: RECRUITING
-
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
NCT00004420 ·Status: COMPLETED ·Phase: NA
-
Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
NCT00078793 ·Status: COMPLETED
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
NCT03781375 ·Status: TERMINATED ·Phase: PHASE3
-
Serum Interleukin - 17A in Juvenile Idiopathic Arthritis
NCT05688358 ·Status: UNKNOWN
-
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset
NCT00512239 ·Status: RECRUITING
-
Choosing Tests Wisely in Rheumatology
NCT03240536 ·Status: COMPLETED ·Phase: NA
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Juvenile Idiopathic Arthritis in Children in Estonia.
NCT01905319 ·Status: COMPLETED
-
Ultrasound Assessment of Steroid Joint Injections in Juvenile Idiopathic Arthritis
NCT01114243 ·Status: WITHDRAWN
-
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
NCT01399281 ·Status: UNKNOWN
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 ·Status: ACTIVE_NOT_RECRUITING
-
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
NCT01513902 ·Status: COMPLETED ·Phase: PHASE1
-
Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment
NCT04540432 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
NCT03265132 ·Status: TERMINATED ·Phase: PHASE3
-
Juvenile Rheumatoid Arthritis
NCT00037648 ·Status: COMPLETED ·Phase: PHASE2
-
Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
NCT00323960 ·Status: COMPLETED ·Phase: PHASE3
-
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
NCT00688545 ·Status: TERMINATED
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430 ·Status: COMPLETED ·Phase: PHASE4
-
Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
NCT02742337 ·Status: UNKNOWN
-
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
NCT00886769 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
NCT00035958 ·Status: TERMINATED ·Phase: PHASE2/PHASE3